Physician profile
Lori Middleton
NPI 1780631945
$1,084.50
in general payments reported to CMS, 2019-2025
12 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2023: $557 · 2024: $161 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.68 |
| Travel and Lodging | $226.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $226.46 | 2023 | Da Vinci Surgical System |
| Teva Pharmaceuticals USA, INC. | $145.97 | 2021-2023 | Austedo Xr |
| Abbvie INC. | $125.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $123.52 | 2024 | Rexulti |
| Acadia Pharmaceuticals INC | $101.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $89.65 | 2021-2023 | Fasenra |
| Genentech USA, INC. | $75.26 | 2023 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $70.64 | 2023-2024 | Takhzyro, Eohilia |
| Glaxosmithkline, LLC. | $61.38 | 2023 | Nucala |
| Ionis Pharmaceuticals, INC. | $28.74 | 2025 | Dawnzera |
| Optinose US, INC. | $18.69 | 2025 | |
| Biocryst US Sales Co., LLC | $17.28 | 2023 | Orladeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.